Mutation to

Pseudomonas aeruginosa SCV aminoglycosides antibiotic resistance burn wound infection gentamicin small-colony variant tobramycin

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
19 07 2022
Historique:
entrez: 19 7 2022
pubmed: 20 7 2022
medline: 22 7 2022
Statut: ppublish

Résumé

Pseudomonas aeruginosa is a major pathogen in burn wound infections. We present one of the first reports of small-colony variant (SCV) emergence of P. aeruginosa, taken from a patient under aminoglycosides for a persistent burn wound infection. We confirm the causative role of a single

Identifiants

pubmed: 35852364
doi: 10.1128/aac.00621-22
pmc: PMC9295567
doi:

Substances chimiques

Aminoglycosides 0
Anti-Bacterial Agents 0
Bacterial Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0062122

Références

Nucleic Acids Res. 2016 Aug 19;44(14):6614-24
pubmed: 27342282
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Nat Rev Microbiol. 2019 Jul;17(7):441-448
pubmed: 30980069
J Bacteriol. 2018 Aug 10;200(17):
pubmed: 29941425
Clin Infect Dis. 1998 Sep;27(3):419-22
pubmed: 9770133
Int J Antimicrob Agents. 2000 Mar;14(2):117-22
pubmed: 10720801
Microb Genom. 2019 Apr;5(4):
pubmed: 30920365
Burns. 2008 Sep;34(6):791-6
pubmed: 18395988
Nat Rev Microbiol. 2006 Apr;4(4):295-305
pubmed: 16541137
Infect Immun. 1997 Sep;65(9):3838-46
pubmed: 9284161
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10714-10719
pubmed: 30275334
Mol Microbiol. 1996 Feb;19(3):599-609
pubmed: 8830250
J Bacteriol. 1997 Aug;179(15):4706-12
pubmed: 9244256
Int J Med Microbiol. 2010 Dec;300(8):557-62
pubmed: 20943439
Nat Biotechnol. 2019 May;37(5):540-546
pubmed: 30936562
Nat Protoc. 2015 Nov;10(11):1820-41
pubmed: 26492139
J Hosp Infect. 2016 Sep;94(1):2-7
pubmed: 27451039
J Infect Dis. 2003 May 15;187(10):1654-61
pubmed: 12721946
J Biochem. 2005 Mar;137(3):395-400
pubmed: 15809342
Avicenna J Med Biotechnol. 2015 Jul-Sep;7(3):113-20
pubmed: 26306151
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28874369
Mol Microbiol. 2015 Mar;95(5):819-32
pubmed: 25491272
Surg Infect (Larchmt). 2021 Feb;22(1):44-48
pubmed: 33085576
PLoS Pathog. 2012;8(6):e1002760
pubmed: 22719254
J Bacteriol. 1989 Oct;171(10):5654-8
pubmed: 2676985
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W181-4
pubmed: 18411202
Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):9767-9772
pubmed: 30209218
Nature. 2002 Apr 18;416(6882):740-3
pubmed: 11961556
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
PLoS Pathog. 2020 Dec 14;16(12):e1009112
pubmed: 33315938
Mol Syst Biol. 2013 Oct 29;9:700
pubmed: 24169403

Auteurs

Melissa Pitton (M)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Berngrid.5734.5, Bern, Switzerland.
Graduate School for Cellular and Biomedical Sciences (GCB), University of Berngrid.5734.5, Bern, Switzerland.

Simone Oberhaensli (S)

Interfaculty Bioinformatics Unit, University of Berngrid.5734.5, Bern Switzerland.
SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Fiona Appiah (F)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Berngrid.5734.5, Bern, Switzerland.

Jean-Luc Pagani (JL)

Service of Intensive Care Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Anne Fournier (A)

Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Stephan M Jakob (SM)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Berngrid.5734.5, Bern, Switzerland.

Yok-Ai Que (YA)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Berngrid.5734.5, Bern, Switzerland.

David R Cameron (DR)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Berngrid.5734.5, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH